6 Multibagger Stocks That Surged After FIIs Corrected Their Mistakes

While Foreign Institutional Investors (FIIs) have largely acted as bears on Dalal Street, a specific pattern of "selective re-entry" has created massive wealth for early movers. In a handful of outlier stocks, FIIs reversed their selling streaks to aggressively accumulate shares, leading to spectacular multibagger returns.

The Anatomy of an FII U-Turn

The most striking examples of this institutional course correction involve stocks where FIIs initially slashed their holdings before pivoting to significant accumulation in the March quarter. According to data from ACE Equity, this directional shift has acted as a powerful catalyst for price appreciation in several mid-cap and small-cap names.

The standout performer in this category is Bajaj Consumer Care, which delivered a staggering 265% return over the past year. FIIs had systematically reduced their stake from 10.95% in June 2025 to 9.7% by December 2025. However, recognizing a potential mispricing, they ramped up holdings to 16.59% in the March 2026 quarter. This pivot saw the stock price climb from Rs 169.8 to Rs 619.7.

High-Growth Performers Driven by Institutional Buying

Other stocks demonstrated that even marginal increases in foreign ownership can signal momentum. Acutaas Chemicals saw FII shareholding grow from 16.94% in June 2025 to 19.48% by March 2026, fueling a 187% price surge from Rs 1,130.75 to Rs 3,248.45.

The list of multibaggers driven by these institutional pivots includes:

  • SML Mahindra: Despite a massive drop in FII holding from 15.73% to just 0.61% in December, a slight pivot in the March quarter accompanied a 124.75% return.
  • Dee Development Engineers: A marginal FII increase from 0.81% to 0.99% supported a 119% rise in stock price.
  • United Foodbrands: After hitting a trough in September 2025, FII accumulation helped the stock appreciate 112% to reach Rs 672.
  • RateGain Travel Technologies: FII ownership rose from a low of 4.97% to 5.35% in March 2026, helping the stock more than double to Rs 873.25.

Diverging Views: What the Smart Money is Planning Next

As the market looks toward the next cycle, institutional strategists remain divided on sector positioning. The outlook depends heavily on macroeconomic variables like US interest rates, crude oil prices, and currency stability.

Nuvama’s strategy team suggests that if global supply-side pressures ease, the next leg of growth will be driven by demand, favoring consumer, chemicals, and IT sectors. Conversely, JM Financial is taking a defensive stance due to rupee weakness and crude volatility, repositioning toward pharma, healthcare, and metals while remaining cautious on banks and automobiles.

In contrast, Tata Mutual Fund is eyeing large caps, anticipating that a potential US slowdown could trigger emerging market inflows, benefiting stable, large-cap Indian corporates. Meanwhile, Bandhan AMC's Manish Gunwani highlights small caps as a highly attractive space for a three-to-five-year horizon, specifically targeting manufacturing and defense infrastructure.

Key Takeaways

  • FII Pivots as Catalysts: Strategic re-entry by foreign investors in stocks like Bajaj Consumer Care and Acutaas Chemicals has preceded massive multibagger gains.
  • Sector Divergence: Market experts are split between defensive plays (Pharma/Healthcare) and growth-oriented sectors (Consumer/IT) depending on macroeconomic stability.
  • Long-term Opportunities: While large caps offer stability against US economic shifts, small caps remain a high-potential area for capturing long-term structural changes in manufacturing and defense.